RBS offers Nordic adventure

The Royal Bank of Scotland (RBS) Global Banking & Markets (GBM) has launched three new products for the Swedish retail market: Autopilot 8, Alpha Centurion 2, and EuropaEttan (effectively a BRC Index Spread).

The capital-guaranteed Autopilot 8, a five-year structured note, is based on the iShares MSCI EAFE Index Fund, the iShares Emerging Markets Index, the FTSE European Public Real Estate Index, the CHF/USD exchange rate, the iPath Dow Jones AIG Commodity Index Total Return and Stibor.

The product, which observes the spot price of each individual basket compared with its rolling moving average, is available with issue price/participations of 100%/100%, 110%/160% and 20.5%/100%. Alpha Centurion 2, a four-year product, is based on the FTSE Eurotop 100 Index. The initial investment will be returned at maturity. The long/short weekly rebalancing strategy is available with issue price/participations of 100%/105%, 110%/210% and 14.5%/100%.

The BRC Index Spread, EuropaEttan, is based on the DJ Eurostoxx Select Dividend 30 and the DJ Eurostoxx 50. The initial investment will be returned at maturity. The strategy is available with issue price/participations of either 103%/160% or 6.5%/160%.

"Investors in the Nordic region have become increasingly interested in capital protection following the collapse of the markets in 2000 and 2001," says Patrick Stockenvall, London-based co-head of Structured Investor Products for the Nordics and Eastern Europe at RBS. "This collapse was felt harder in the Scandinavian stock market, which relied heavily on high-tech stocks such as Ericsson and Nokia, but investors have retained a degree of adventurousness and there is enthusiasm for low-risk, exotic, alpha-generating and hedge-fund-type investments," he says.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here